Using metformin to reduce the risk of blood vessel complications – COMPLETED
Scientific title: REMOVAL study: REducing with MetfOrmin Vascular Adverse Lesions in type 1 diabetes
Principal Investigator: Professor John Petrie
Institution: University of Glasgow
Project duration: 01/02/2010 – 31/07/2017
Objective: The objective of REMOVAL is to test whether metformin tablets, when taken alongside a person’s usual insulin injections in type 1 diabetes, can prevent the early blood vessel damage that can lead to heart attacks and stroke.
Categories: Treat, Strategic Research Agreement, Complications